ro 46-2005 has been researched along with cilazapril, anhydrous in 1 studies
| Studies (ro 46-2005) | Trials (ro 46-2005) | Recent Studies (post-2010) (ro 46-2005) | Studies (cilazapril, anhydrous) | Trials (cilazapril, anhydrous) | Recent Studies (post-2010) (cilazapril, anhydrous) |
|---|---|---|---|---|---|
| 26 | 0 | 1 | 545 | 189 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruneval, P; Clozel, JP; Clozel, M; Heudes, D; Osterwalder, R; Qiu, C; Roeckel, A | 1 |
1 other study(ies) available for ro 46-2005 and cilazapril, anhydrous
| Article | Year |
|---|---|
Effects of nonpeptide endothelin receptor antagonists in rats with reduced renal mass.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bosentan; Cilazapril; Endothelin Receptor Antagonists; Kidney; Kidney Function Tests; Male; Organ Size; Proteinuria; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Sulfonamides | 1999 |